Korean Drug Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 12.77%

Korean Drug Co. Ltd (014570) has an Asset Resilience Ratio of 12.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 014570 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩12.14 Billion

≈ $8.22 Million USD Cash + Short-term Investments

Total Assets

₩95.05 Billion

≈ $64.41 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Korean Drug Co. Ltd's Asset Resilience Ratio has changed over time. See 014570 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Korean Drug Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Korean Drug Co. Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩12.14 Billion	12.77%
Total Liquid Assets	₩12.14 Billion	12.77%

Asset Resilience Insights

Moderate Liquidity: Korean Drug Co. Ltd has 12.77% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Korean Drug Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Korean Drug Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Roche Holding AG SW:ROG	Drug Manufacturers - General	15.37%
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	2.74%
CSPC Pharmaceutical Group Limited F:CVG	Drug Manufacturers - General	4.64%
AstraZeneca PLC LSE:AZN	Drug Manufacturers - General	0.03%
Yifan Xinfu Pharmaceutical Co Ltd SHE:002019	Drug Manufacturers - General	0.53%
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	Drug Manufacturers - General	5.37%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	10.10%

Annual Asset Resilience Ratio for Korean Drug Co. Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Korean Drug Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	21.33%	₩18.96 Billion ≈ $12.85 Million	₩88.89 Billion ≈ $60.24 Million	+2.78pp
2023-12-31	18.55%	₩16.64 Billion ≈ $11.28 Million	₩89.71 Billion ≈ $60.79 Million	-9.21pp
2022-12-31	27.76%	₩26.23 Billion ≈ $17.78 Million	₩94.52 Billion ≈ $64.05 Million	-3.52pp
2021-12-31	31.28%	₩27.72 Billion ≈ $18.78 Million	₩88.61 Billion ≈ $60.05 Million	+4.80pp
2020-12-31	26.48%	₩22.07 Billion ≈ $14.95 Million	₩83.34 Billion ≈ $56.48 Million	+11.50pp
2019-12-31	14.98%	₩11.36 Billion ≈ $7.70 Million	₩75.85 Billion ≈ $51.40 Million	+3.16pp
2018-12-31	11.82%	₩8.62 Billion ≈ $5.84 Million	₩72.96 Billion ≈ $49.45 Million	+7.10pp
2017-12-31	4.71%	₩3.15 Billion ≈ $2.13 Million	₩66.79 Billion ≈ $45.27 Million	-1.58pp
2016-12-31	6.30%	₩3.99 Billion ≈ $2.71 Million	₩63.41 Billion ≈ $42.97 Million	+5.71pp
2015-12-31	0.59%	₩350.05 Million ≈ $237.22K	₩59.20 Billion ≈ $40.12 Million	+0.58pp
2014-12-31	0.01%	₩4.68 Million ≈ $3.17K	₩62.17 Billion ≈ $42.13 Million	--

pp = percentage points

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General

Market Cap

$30.72 Million

₩45.33 Billion KRW

Market Cap Rank

#23640 Global

#1699 in Korea

Share Price

₩4190.00

Change (1 day)

-1.30%

52-Week Range

₩3765.00 - ₩4975.00

All Time High

₩13030.58